Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
PLoS One
2016 Jan 01;1111:e0166367. doi: 10.1371/journal.pone.0166367.
Show Gene links
Show Anatomy links
Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency.
Molino CG
,
Romano-Lieber NS
,
Ribeiro E
,
de Melo DO
.
???displayArticle.abstract???
BACKGROUND: Annually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of these deaths. High-quality clinical practice guidelines (CPGs) are fundamental to improving NCD management. The present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs.
METHODS: We conducted a systematic search for CPGs of the following NCDs: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. CPGs comprising pharmacological treatment recommendations were included. No language or year restrictions were applied. CPGs were excluded if they were merely for local use and referred to NCDs not listed above. CPG quality was independently assessed by two reviewers using the Appraisal of Guidelines Research and Evaluation instrument, version II (AGREE II).
MAIN FINDINGS: "Scope and purpose" and "clarity and presentation" domains received the highest scores. Sixteen of 26 CPGs were classified as low quality, and none were classified as high overall quality. No CPG was recommended without modification (77% were not recommended at all). After 2009, 2 domain scores ("rigor of development" and "clarity and presentation") increased (61% and 73%, respectively). However, "rigor of development" was still rated < 30%.
CONCLUSION: Brazilian healthcare professionals should be concerned with CPG quality for the treatment of selected NCDs. Features that undermined AGREE II scores included the lack of a multidisciplinary team for the development group, no consideration of patients'' preferences, insufficient information regarding literature searches, lack of selection criteria, formulating recommendations, authors'' conflict of interest disclosures, and funding body influence.
???displayArticle.pubmedLink???
27846245
???displayArticle.pmcLink???PMC5112889 ???displayArticle.link???PLoS One
Fig 1. Flowchart of clinical practice guidelines selection.
Fig 2. Overall quality classification of Brazilian CPGs (n = 26) for the treatment of the most prevalent NCDs.
Fig 3. AGREE II scores obtained, per domain, based on publication year (before and in/after 2009, publication of AGREE II) for Brazilian CPGs.(*) Statistical significant was observed for “rigor of development” (p = 0.03) and “clarity and presentation (p = 0.01).”
Al-Ansary,
A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension.
2013, Pubmed
Al-Ansary,
A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension.
2013,
Pubmed
Alonso-Coello,
The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies.
2010,
Pubmed
Bancos,
Endocrine clinical practice guidelines in North America. A systematic assessment of quality.
2012,
Pubmed
Bocchi,
[Updating of the Brazilian guideline for chronic heart failure - 2012].
2012,
Pubmed
Bodenheimer,
Improving primary care for patients with chronic illness.
2002,
Pubmed
Bower,
Multimorbidity, service organization and clinical decision making in primary care: a qualitative study.
2011,
Pubmed
Brouwers,
AGREE II: advancing guideline development, reporting and evaluation in health care.
2010,
Pubmed
Cabana,
Why don't physicians follow clinical practice guidelines? A framework for improvement.
1999,
Pubmed
Cesar,
Guideline for stable coronary artery disease.
2014,
Pubmed
Chen,
Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.
2015,
Pubmed
Chen,
Quality assessment of clinical guidelines in China: 1993 - 2010.
2012,
Pubmed
Fenelon,
Atrial fibrillation ablation in Brazil: results of the registry of the Brazilian Society of Cardiac Arrhythmias.
2007,
Pubmed
Fretheim,
Improving the use of research evidence in guideline development: 3. Group composition and consultation process.
2006,
Pubmed
Graham,
2011,
Pubmed
Grilli,
Practice guidelines developed by specialty societies: the need for a critical appraisal.
2000,
Pubmed
Guiding principles for the care of older adults with multimorbidity: an approach for clinicians,
Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.
2012,
Pubmed
Haines,
Implementing findings of research.
1994,
Pubmed
Hu,
The quality of clinical practice guidelines in China: a systematic assessment.
2013,
Pubmed
Hudon,
Patient-centered care in chronic disease management: a thematic analysis of the literature in family medicine.
2012,
Pubmed
Jiang,
Quality Assessment of Clinical Practice Guidelines for Respiratory Diseases in China: A Systematic Appraisal.
2015,
Pubmed
Khan,
[Cross-cultural adaptation of the instrument Appraisal of Guidelines For Research & Evaluation II (AGREE II) for assessment of clinical guidelines].
2014,
Pubmed
Knai,
Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe.
2012,
Pubmed
Kryworuchko,
Twelve years of clinical practice guideline development, dissemination and evaluation in Canada (1994 to 2005).
2009,
Pubmed
Kung,
Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress.
2012,
Pubmed
Kunz,
Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
2012,
Pubmed
Landis,
The measurement of observer agreement for categorical data.
1977,
Pubmed
Lefèvre,
What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization.
2014,
Pubmed
Legido-Quigley,
Clinical guidelines in the European Union: mapping the regulatory basis, development, quality control, implementation and evaluation across member states.
2012,
Pubmed
Lorgunpai,
Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.
2014,
Pubmed
Marengoni,
Aging with multimorbidity: a systematic review of the literature.
2011,
Pubmed
Menotti,
Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly).
2001,
Pubmed
Murthy,
Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians.
2012,
Pubmed
Norris,
Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse.
2012,
Pubmed
Piano,
Guidelines for neuropathic pain management in patients with cancer: a European survey and comparison.
2013,
Pubmed
Poitras,
A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria.
2007,
Pubmed
Ronsoni,
[Evaluation of eight Clinical Protocols and Therapeutic Guidelines under the Brazilian Ministry of Health using the AGREE II instrument: a pilot study].
2015,
Pubmed
Schmidt,
Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil).
2015,
Pubmed
Serón,
Evaluation of the quality of clinical guidelines for cardiac rehabilitation: a critical review.
2015,
Pubmed
Shaneyfelt,
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature.
1999,
Pubmed
Siering,
Appraisal tools for clinical practice guidelines: a systematic review.
2013,
Pubmed
Smith,
A Systematic Critical Appraisal of Clinical Practice Guidelines in Juvenile Idiopathic Arthritis Using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument.
2015,
Pubmed
Smith,
Managing patients with multimorbidity: systematic review of interventions in primary care and community settings.
2012,
Pubmed
Soeiro,
[Not Available].
2014,
Pubmed
Tudor,
Methodological rigour and transparency of clinical practice guidelines developed by neurology professional societies in Croatia.
2013,
Pubmed
Vitry,
Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions.
2008,
Pubmed
Vlayen,
A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit.
2005,
Pubmed
Wagner,
Improving outcomes in chronic illness.
1996,
Pubmed
Wagner,
Organizing care for patients with chronic illness.
1996,
Pubmed
Woolf,
Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.
1999,
Pubmed
Xavier,
[V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis].
2013,
Pubmed
Yan,
Diagnosis of pheochromocytoma: a clinical practice guideline appraisal using AGREE II instrument.
2013,
Pubmed
Zhang,
Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrument.
2014,
Pubmed
da Mota,
2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis.
2012,
Pubmed
